Literature DB >> 10074372

Selection and characterization of an RNA decoy for transcription factor NF-kappa B.

L L Lebruska1, L J Maher.   

Abstract

Despite their chemical similarity, DNA and RNA sequences typically adopt very different structures within cells and are recognized by different proteins. However, a few interesting examples of proteins with dual specificity for DNA and RNA have previously been noted. These observations raise the possibility that RNA surrogates might be identified for many transcription factors that normally bind DNA. As an initial test of this novel concept, we used in vitro selection to isolate a small RNA aptamer that binds with nanomolar affinity to human transcription factor NF-kappa B, a key regulator of inflammation, HIV-1 gene expression, and apoptosis. Selected RNAs contain a 31-nucleotide core domain that was shown by mutation and deletion analyses to be necessary and sufficient for NF-kappa B binding. Neither DNA nor 2'-O-methyl RNA analogues of the aptamer bound NF-kappa B. The results of competition experiments demonstrate that binding of the RNA aptamer blocks the ability of NF-kappa B to bind duplex DNA. Expression of this aptamer structure within heterologous nuclear RNA transcripts may provide a new strategy to inhibit NF-kappa B function in vivo. Aptamers that inhibit transcription factors might be useful in a variety of applications.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10074372     DOI: 10.1021/bi982515x

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  54 in total

Review 1.  Chemical approaches to control gene expression.

Authors:  J M Gottesfeld; J M Turner; P B Dervan
Journal:  Gene Expr       Date:  2000

Review 2.  Therapeutic applications of transcription factor decoy oligonucleotides.

Authors:  M J Mann; V J Dzau
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

3.  Transcriptional silencing and promoter methylation triggered by double-stranded RNA.

Authors:  M F Mette; W Aufsatz; J van der Winden; M A Matzke; A J Matzke
Journal:  EMBO J       Date:  2000-10-02       Impact factor: 11.598

4.  Construction and selection of bead-bound combinatorial oligonucleoside phosphorothioate and phosphorodithioate aptamer libraries designed for rapid PCR-based sequencing.

Authors:  Xianbin Yang; Suzanne E Bassett; Xin Li; Bruce A Luxon; Norbert K Herzog; Robert E Shope; Judy Aronson; Tarl W Prow; James F Leary; Romy Kirby; Andrew D Ellington; David G Gorenstein
Journal:  Nucleic Acids Res       Date:  2002-12-01       Impact factor: 16.971

5.  Aptamer database.

Authors:  Jennifer F Lee; Jay R Hesselberth; Lauren Ancel Meyers; Andrew D Ellington
Journal:  Nucleic Acids Res       Date:  2004-01-01       Impact factor: 16.971

6.  Targeting a KH-domain protein with RNA decoys.

Authors:  Aleksandr V Makeyev; Dawn L Eastmond; Stephen A Liebhaber
Journal:  RNA       Date:  2002-09       Impact factor: 4.942

7.  Crystal structure of NF-kappaB (p50)2 complexed to a high-affinity RNA aptamer.

Authors:  De-Bin Huang; Don Vu; Laura A Cassiday; Jeff M Zimmerman; L James Maher; Gourisankar Ghosh
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-28       Impact factor: 11.205

8.  In vivo selection of spectinomycin-binding RNAs.

Authors:  Jeff M Zimmerman; L James Maher
Journal:  Nucleic Acids Res       Date:  2002-12-15       Impact factor: 16.971

9.  In search of novel drug target sites on estrogen receptors using RNA aptamers.

Authors:  Daiying Xu; Vamsee-Krishna Chatakonda; Antonis Kourtidis; Douglas S Conklin; Hua Shi
Journal:  Nucleic Acid Ther       Date:  2014-03-03       Impact factor: 5.486

Review 10.  Aptamers and the next generation of diagnostic reagents.

Authors:  Varatharasa Thiviyanathan; David G Gorenstein
Journal:  Proteomics Clin Appl       Date:  2012-12       Impact factor: 3.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.